An implanted chip converts glucose into a safe substance and reduces weight by 10%
A recent scientific study, published by Live Science , revealed an experimental medical implant that showed promising results in treating type 2 diabetes and obesity, after it succeeded in removing excess sugar from the blood and stimulating fat burning during experiments conducted on laboratory mice. The innovation relies on a small device that is implanted inside the body and works in conjunction with continuous glucose monitoring devices, allowing for real-time monitoring of sugar levels and automatic adjustment according to the patient's needs. Researchers, led by Martin Fussenegger of the Swiss Federal Institute of Technology in Zurich, have developed a miniature reactor, about an inch long, that converts excess glucose into a harmless substance known as gluconate. This is achieved through a chemical reaction catalyzed by minute amounts of electricity, using electrodes coated with gold and platinum nanoparticles. The importance of the technology lies in the fact that the glucose removal process can be precisely switched on or off by controlling the amount of electricity sent to the implant, which helps to avoid sugar dropping to dangerous levels. The device is also wirelessly operated by a smartphone that sends low-energy radio waves to the implant. When a rise in blood sugar is detected, the monitoring system sends a signal to the phone, which then adjusts the energy required to activate the chemical reaction. Scientists tested the device on diabetic and obese mice for six weeks. The results showed a significant stabilization of blood sugar levels compared to untreated animals, in addition to an average weight loss of about 10%. Researchers believe that maintaining glucose levels within normal ranges has led the body to rely more on burning fat as an energy source, which has contributed to weight loss and improved metabolic indicators. Innovation is particularly important given the global prevalence of these two diseases, with approximately 790 million people suffering from type 2 diabetes and over one billion people living with obesity. Furthermore, the vast majority of people with type 2 diabetes are overweight or obese. Despite the encouraging results, researchers emphasize that the implant is not a substitute for healthy nutrition, physical activity, or currently approved treatments, but it may represent an additional therapeutic tool in the future that can be used alongside medications and lifestyle modifications to reduce the effects of diabetes and obesity.
0 Comments